Who has invested in BioRay Pharmaceuticals?

PAG are named among the investors backing BioRay Pharmaceuticals.

BioRay Pharmaceuticals Funding: $369M Raised, Growth (2023)

BioRay Pharmaceuticals funding overview

BioRay Pharmaceuticals is based in Taizhou, Zhejiang, China. BioRay Pharmaceuticals has raised $369M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in January 2023. The round record for BioRay Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include PAG.

BioRay Pharmaceuticals at a glance

Total raised: $369M
Latest round: Growth
Latest round date: January 2023
Headquarters: Taizhou, Zhejiang, China
Notable investors: PAG

Frequently asked about BioRay Pharmaceuticals funding

How much has BioRay Pharmaceuticals raised?: BioRay Pharmaceuticals has raised $369M in total disclosed funding across the rounds on record.
Who has invested in BioRay Pharmaceuticals?: PAG are named among the investors backing BioRay Pharmaceuticals.
What was the latest BioRay Pharmaceuticals funding round?: The most recent disclosed round is a Growth, announced in January 2023.
Where is BioRay Pharmaceuticals based?: BioRay Pharmaceuticals is based in Taizhou, Zhejiang, China.
When did BioRay Pharmaceuticals last raise?: The last disclosed BioRay Pharmaceuticals round closed in January 2023 at Growth.

BioRay Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Taizhou below to benchmark round size and investor mix.

BioRay Pharmaceuticals Funding: $369M Raised, Growth (2023)

BioRay Pharmaceuticals funding overview

BioRay Pharmaceuticals at a glance

Frequently asked about BioRay Pharmaceuticals funding

Companies related to BioRay Pharmaceuticals (40)

Browse related funding lists (3)